Sign up for the QMED & MD+DI Daily newsletter.
BD Launches SiteRite 9 Ultrasound System
The system offers enhanced image quality and vessel assessment tools to aid in catheter insertion.
December 4, 2023
1 Min Read
Image courtesy of PR Newswire
Becton, Dickinson and Company (BD) recently announced the launch of its SiteRite 9 Ultrasound System in the United States market. The system received 510(k) clearance in September and is part of the company’s vascular access management portfolio.
The device is designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines, and other vascular access devices. It is user-friendly and updated with a 15.5-inch touch screen with enhanced image quality that “provides industry-leading catheter placement tools and technologies to support clinicians during the vascular access device insertion process,” according to the press release announcing the launch.
Additionally, the system includes integrated visualization tools like the Cue Needle Tracking System to provide continuous and real-time needle tracking and the Sherlock 3CG+ Tip Confirmation System to ensure correct catheter tip navigation and location. SiteRite 9 also features vessel assessment tools that automatically detect the vessel and then pair with vessel measurement tools to help clinicians choose the right catheter. Other system capabilities include patient data look up with information capture, autofilling capabilities, and records transfer.
"Our latest innovation in ultrasound technology is designed to make vascular access care delivery easier and more efficient for clinicians — whether they've been on the job for years or are new to the field," said Eric Borin, worldwide president of medication delivery solutions at BD, in the release. "By combining our decades of leadership in vascular access with voice-of-the-customer enhancements, we've developed a best-in-class solution to aid in insertion success on the first attempt and reduce the need for repeated needlesticks to deliver a better care experience for everyone involved."
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read